Aptose Biosciences Inc (APTOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 05-2013 | 03-2013 | 02-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 650 | N/A | 1,550 | N/A | 2,850 |
| Other current assets | 360 | 0 | 260 | 0 | 370 |
| TOTAL | $1,010 | $N/A | $1,810 | $N/A | $3,220 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $1,030 | $N/A | $1,840 | $N/A | $3,250 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 710 | 0 | 210 | 0 | 330 |
| Accrued Expenses | 1,090 | N/A | 1,220 | N/A | 1,270 |
| TOTAL | $1,800 | $N/A | $1,430 | $N/A | $1,600 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,800 | $N/A | $1,430 | $N/A | $1,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 8 | N/A | N/A | N/A |
| Common Shares | 173,850 | N/A | 175,230 | N/A | 176,750 |
| Retained earnings | -199,190 | N/A | -199,450 | N/A | -199,790 |
| Other shareholders' equity | 3,440 | 0 | 3,320 | 0 | 3,210 |
| TOTAL | $-770 | $N/A | $400 | $N/A | $1,650 |
| Total Liabilities And Equity | $1,030 | $0 | $1,830 | $0 | $3,250 |